FeesSafety
Pluang+

Priority Technology sale at $8.05/share under review for fairness by law firm KSF.

Company Fundamentals
11 Nov 2026, 21:29 WIB
PRNewsWire
View Source
Bearish
Priority Technology sale at $8.05/share under review for fairness by law firm KSF.

Priority Technology Holdings is proposed to be sold to an investor group led by its CEO, Thomas Priore, at $8.05 per share. The law firm Kahn Swick & Foti, LLC, including former Louisiana Attorney General Charles C. Foti, Jr., is investigating whether this offer fairly values the company. They are assessing if the sale price and process are adequate or if shareholders are being undervalued. Shareholders concerned about the deal can contact KSF for legal advice at no cost.

Priority Technology Holdings is the subject of a legal investigation into its proposed sale price and process. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 11, 2026 23:11 WIB: out of 150 priced US Technology stocks, 118 rose and 32 fell. Notable movers include SMCI at USD 30.73 with a 10.56% increase and a typical hold time of 22 days, BTDR at USD 7.04 up 9.83% with 82% buy order activity, and CIFR at USD 7.15 rising 9.49% with 83% sell order activity.

More News

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...

Market News
Bullish
1 hour ago
Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...

Bullish
1 hour ago
Dylanex offers key Q4 inventory tips for Amazon sellers to avoid stock-outs and manage holiday demand.

Dylanex offers key Q4 inventory tips for Amazon sellers to avoid stock-outs and manage holiday demand.

Dylanex has released practical guidance for Amazon sellers to prepare inventory for the busy Q4 holiday season. The advice focuses on managing inbound shipment timing, avoiding preparation errors, planning around restock limits, and using reserve sto...

Market News
Neutral
4 hours ago
Australia project logistics market to grow to $10.27B by 2031, driven by mining and renewable energy projects

Australia project logistics market to grow to $10.27B by 2031, driven by mining and renewable energy projects

The Australia project logistics market is projected to grow from USD 7.88 billion in 2026 to USD 10.27 billion by 2031, at a CAGR of 5.52%. Growth is fueled by mining and energy projects requiring transport of oversized cargo, and expanding renewable...

Market News
Bullish
4 hours ago
Bitmine reports $6.3B net loss as Ethereum price drops 44% in fiscal 2026 year

Bitmine reports $6.3B net loss as Ethereum price drops 44% in fiscal 2026 year

Bitmine Immersion Technologies posted a $6.31 billion net loss for fiscal year 2026, driven by a $6.23 billion unrealized loss on its Ethereum holdings amid a 44% drop in ETH price. Despite revenue growth to $124.8 million from staking activities, hi...

Protocol Fundamentals
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App